- Home
- About Us
- Conferences
- Patients
- Press and Articles
- Press Releases
- TARGIT - A
- TARGIT - E
- TARGIT - R
- DCIS Articles
- INTRAGO Articles
- General IORT
- IORT in Special Situations
- Cost Effectiveness of IORT
- IORT as a Boost
- Brain Tumors - GBM
- Brain Tumors - Brain Metastases
- Corona Virus & Radiation Options
- Spine Metastases
- Cosmesis After IORT
- Physics of IORT
- Soft Tissue Sarcoma
- Past Articles
- Resources
- QC Registry
- Membership
|
The TARGIT Collaborative Group (TCG) is a cooperative effort between radiation oncologists, cancer surgeons, physicists and other experts in intraoperative radiotherapy that share a common commitment to improving cancer patient care through education, patient advocacy, mentorship, and collaborative research.
TARGIT Collaborative GroupThe TARGIT Collaborative Group website is for health care professionals and professional members of the TARGIT Collaborative Group. Non-healthcare providers seeking general information about TARGIT-IORT single-dose treatment for breast cancer, please visit www.targetbreastcancer.org. The ASTRO Partial Breast Irradiation (PBI) 2023 Guideline has NOT CHANGED for TARGIT-IORT.CMS (MediCare) continues to reimburse TARGIT-IORT as do many insurance companies. If you want to be part of an IORT Registry, please join our Quality Collaborative Registry! Our TCG QC Registry is FREE with TCG Membership. Website Updates: Press and ArticlesFind articles on a variety of topics including TARGIT-A and General IORT. TARGIT-A Press Release
Recently Published Study Shows Effective Treatment for Early-Stage Breast Cancer Click Here to view recently updated TARGIT - A videos and Articles.
|
Platinum Sponsor
Exhibitors & Sponsors
